ADIA is the peak business organisation representing manufacturers and suppliers of dental products. Our vision is for an industry that empowers oral health professionals to advance the health and wellbeing of all Australians...................... — ADIA Strategic Plan

News

TPP-11 Agreement Presented To Parliament

TPP-11 Agreement Presented To Parliament

10th Apr 18

Summary —

In the next step towards ratification of and important free trade agreement that will support the dental industry, the TPP-11 agreement was presented to the Australian Parliament where it will undergo parliamentary committee scrutiny.

Key Issues For The Dental Industry —

The Comprehensive and Progressive Agreement for Trans-Pacific Partnership (TPP-11) is a regional free trade agreement of unprecedented scope and ambition with great potential to drive job-creating growth across the Australian economy, including the dental industry.  It was presented to the Australian parliament on 26 March 2018, a move that facilitates the review of the agreement by the parliament's Joint Standing Committee on Treaties.

For the dental industry and the medical devices sector more broadly, the TPP-11 agreement will improve the information available to importers and exporters and reduce unnecessary delays in approvals, improving standard-setting. The TPP-11 will support the expansion of Australian health exports across the Asia-Pacific through outcomes including:

 

TPP Outcomes For The Heath Sector —

  The TPP-11 agreement will eliminate all remaining duties on medical instruments and devices and Australian exports of medical instruments and devices to TPP Parties, which were valued at approximately $1.3 billion in 2015-16. 
  The TPP-11 agreement will also eliminate all remaining duties on Australian pharmaceutical exports which were valued at around $716 million in 2015-16.
  Commitments from Malaysia, Mexico and Vietnam will give Australian providers of private health and allied health services greater certainty regarding access and operating conditions in these markets;
  Disciplines on State-owned Enterprises (SOEs) will help ensure Australian manufacturers of pharmaceutical products and medical devices can compete on a more level playing-field with state-owned manufacturers in other TPP-11 Parties.
  New government procurement opportunities to provide health and welfare services in Brunei Darussalam, Malaysia and Peru;
  Commitments from all TPP Parties that will allow Australian suppliers to bid for pharmaceutical and medical equipment government procurement contracts; and
  Commitments from all TPP Parties in relation to government purchasing by the health department or ministry.

.
The TPP-11 Healthcare Transparency Annex includes provisions on transparency and procedural fairness for the listing of pharmaceuticals for reimbursement.  These provisions are consistent with Australia’s existing procedures and will not require any changes to the Pharmaceutical Benefits Scheme. The Annex does not include commitments relating to the pricing of pharmaceuticals.

The Annex is not subject to any form of dispute settlement, including Investor-State Dispute Settlement (ISDS) provisions.  The TPP-11 ISDS mechanism includes a suite of provisions protecting the Australian Government’s ability to regulate for public health and other public interest objectives.

In addition, the TBT Annexes on Pharmaceutical Products, Medical Devices and Cosmetics will improve the information available to importers and exporters and reduce unnecessary delays in approvals, improving standard-setting in TPP-11 countries for these industries.  Australia’s total exports to TPP-11 countries for these three industries were worth nearly $2.8 billion in 2015-16.  The Annexes do not impose specific requirements or standards for any products.  Australia’s ability to set requirements and standards, including for testing and certification, through the Therapeutic Goods Administration (TGA) will not be affected. 

The agreement was concluded when it was signed on 8 March 2018 by eleven countries - Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. 

The Australian Dental Industry Association (ADIA) has been a strong supporter of the TPP and involved in Australian Government consultations with industry given that the free trade agreement will work to reduce technical barriers to trade in dental products, and medical devices more generally, amongst TPP signatory nations.

Through the ADIA-TCPC Trade & Commercial Policy Committee the dental industry will continue to work with the Australian Government to ensure that businesses in the dental industry understand and benefit from this important agreement.

Member Engagement —

The association's policy advocacy on international trade policy is undertaken by the team within the ADIA whom receive advice and guidance from employees of member businesses serving on the ADIA-TCPC Trade & Commercial Policy Regulation Committee.  Member updates are provided at the quarterly series of ADIA State Branch Briefings.

Further Information —

For further information on ADIA's international trade policy advocacy send an email to advocacy@adia.org.au or telephone 1300 943 094.  To keep up to date follow ADIA on Facebook at www.facebook.com/dental.industry or subscribe to the Twitter feed @AusDental.

Currency Of Information & Disclaimer —

This update was issued on 10 April 2018 and please note that changes in circumstances after the publication of material or information may impact upon its accuracy and also change regulatory compliance obligations. The statements, regulatory and technical information contained herein are believed to be accurate and are provided for information purposes only. Readers are responsible for assessing its relevance and verifying the accuracy of the content. To the fullest extent permitted by law, ADIA will not be liable for any loss, damage, cost or expense incurred in relation to or arising as a result of relying on the information presented here. 

 


This information is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, other images and where otherwise stated.

A.. A D I A . .S T R A T G E G I C . .A L L I A N C E S
* To download these files you'll need ADIA Member Plus access.
 

a

Dental Industry News

  • 2018 ADIA Victorian Dental Show Momentum Builds

    26th Jun 18

    Dentists and allied oral healthcare professionals are planning their attendance at the 2018 ADIA Victorian Dental Show, an event that allows them to meet with the leading suppliers of the products used in dentistry. More

  • TGA Plan To Achieve Global Regulatory Harmonisation

    28th Sep 18

    The Therapeutic Goods Administration (TGA) has released its operations plan to harmonise Australia’s regulatory framework for therapeutic products with that of comparable overseas jurisdictions, which will cut red-tape and make it ea More